Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF264 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C17orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929219 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYCP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HINT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C21orf62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DACT3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL21A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPT-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53TG3HP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on